Medexus Pharmaceuticals Inc.
MEDXF
$1.77
-$0.01-0.56%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 733.00K | 110.00K | 1.96M | 762.00K | -534.00K |
| Total Depreciation and Amortization | 1.76M | 1.58M | 1.41M | 1.45M | 1.45M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.93M | 3.62M | 2.44M | 1.04M | 1.13M |
| Change in Net Operating Assets | 1.29M | 1.55M | 2.38M | -1.65M | 3.50M |
| Cash from Operations | 6.71M | 6.86M | 8.19M | 1.61M | 5.54M |
| Capital Expenditure | -61.00K | -37.00K | -32.00K | -2.00K | -4.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -375.00K | -445.00K | -445.00K | -320.00K | -1.75M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -43.00K | -2.50M | -- | -216.00K | -- |
| Cash from Investing | -479.00K | -2.98M | -477.00K | -538.00K | -1.75M |
| Total Debt Issued | -- | -- | -- | 17.58M | -- |
| Total Debt Repaid | -3.36M | -4.16M | -3.36M | -2.70M | -39.38M |
| Issuance of Common Stock | -- | -- | -- | -- | 25.19M |
| Repurchase of Common Stock | -- | -- | -- | -17.58M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.10M | -1.25M | -1.14M | -1.27M | -970.00K |
| Cash from Financing | -4.46M | -5.41M | -4.50M | -3.96M | -15.16M |
| Foreign Exchange rate Adjustments | -302.00K | 60.00K | -22.00K | -67.00K | 80.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.47M | -1.48M | 3.20M | -2.96M | -11.29M |